In addition, as NRG1 could suppress stroke-induced pro-inflammatory and stress-related gene expressions, which are related with the molecular mechanisms of MSCs in ischemic stroke [24, 26], NRG1 can be an attractive target for MSCs modification to maximize therapeutic efficacies of cell-based therapy. This evidence concerns the gene NRG1 and ischemic stroke.